Correlation Between Pasithea Therapeutics and Royalty Pharma
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Royalty Pharma Plc, you can compare the effects of market volatilities on Pasithea Therapeutics and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Royalty Pharma.
Diversification Opportunities for Pasithea Therapeutics and Royalty Pharma
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pasithea and Royalty is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Royalty Pharma go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Royalty Pharma
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to under-perform the Royalty Pharma. In addition to that, Pasithea Therapeutics is 4.8 times more volatile than Royalty Pharma Plc. It trades about -0.04 of its total potential returns per unit of risk. Royalty Pharma Plc is currently generating about -0.05 per unit of volatility. If you would invest 2,697 in Royalty Pharma Plc on August 31, 2024 and sell it today you would lose (37.00) from holding Royalty Pharma Plc or give up 1.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 50.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Royalty Pharma Plc
Performance |
| Timeline |
| Pasithea Therapeutics |
| Royalty Pharma Plc |
Pasithea Therapeutics and Royalty Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Royalty Pharma
The main advantage of trading using opposite Pasithea Therapeutics and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.| Pasithea Therapeutics vs. Cue Biopharma | Pasithea Therapeutics vs. Tff Pharmaceuticals | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Inhibrx |
| Royalty Pharma vs. Prime Medicine, Common | Royalty Pharma vs. Ginkgo Bioworks Holdings | Royalty Pharma vs. Ocean Biomedical | Royalty Pharma vs. Adaptive Biotechnologies Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |